Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and âindividualizedâ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟